Amgen's experimental jab causes 20 per cent weight loss in early results
Amgen's experimental weight loss injection, MariTide, showed up to 20% weight loss in patients without diabetes and 17% in ...
biopharma-reporter19h
Amgen announces positive Phase 2 results for its GLP-1-GIP weight loss drug
MariTide is being studied for the treatment of obesity and Type 2 diabetes and demonstrated weight loss at 52 weeks.
PipelineReview.com23h
Amgen announces robust weight loss with maritide in people living with obesity or overweight at 52 weeks in a phase 2 study
MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight ...
What if every germ hit you at the exact same time? An immunologist explains
Your immune system is often able to fend off pathogens it’s never seen before. But defending your body against all of them ...
Talksport20h
Premier League LIVE: Van Nistelrooy set to become Leicester manager, Rodri targets early return from injury, James fitness update
Asked for his overriding emotions following the loss, Rooney told talkSPORT: "Disappointed, frustrated. I think this year they've seen a lot of positives from us and tonight was nowhere near good ...
NDTV12h
Food News
In the clip, the vlogger's grandparents were the first to try the regular version of the tablet. After popping it in their mouths they were seen squinting their eyes. Viral video showcases Gulab Jamun ...